Telerehabilitation Robotics for Upper Limb Rehabilitation After STroke
Launched by TAN TOCK SENG HOSPITAL · Feb 14, 2024
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring the use of robotic technology to help people recover their arm movement after a stroke. Many stroke survivors experience a decline in their ability to use their affected arm after leaving the hospital because they don’t receive enough therapy at home. The goal of this study is to provide additional support through robotic exercises that can be done at home, helping patients regain their strength and functionality.
To participate in this trial, individuals must be between 21 and 90 years old, have had a stroke at least 28 days prior, and show some level of difficulty with arm movement. They also need to have a stable home environment and someone to assist them during the exercises. Participants can expect to engage in home-based training sessions that involve using robotic devices designed to improve their motor skills. It’s important to note that the study is currently looking for volunteers, and a thorough screening will be conducted to ensure safety and suitability for the program.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Clinical stroke (ischaemic or haemorrhagic) confirmed by admitting doctors and CT, CT angiography or MRI brain imaging.
- • 2. Age 21 to 90 years, both males and females.
- • 3. At least \> 28 days post stroke.
- • 4. Upper limb motor impairment of Fugl-Myer Motor Assessment (FMA) scale 10 to 60
- • 5. Has a stable home abode and a carer/ NOK to supervise home based exercise.
- • 6. Ability to sit supported continuously for 60 minutes.
- • 7. Montreal Cognitive Assessment (MOCA) score \> 21/30
- • 8. Able to understand purpose of research and give consent.
- Exclusion Criteria:
- • 1. Non-stroke related causes of arm motor impairment.
- • 2. Medical conditions incompatible with research participation: uncontrolled medical illnesses (hypertension or diabetes, ischaemic heart disease, congestive heart failure, bronchial asthma, end stage renal/liver/heart/lung failure, unresolved cancers.
- • 3. Anticipated life expectancy of \< 6 months.
- • 4. Inability to tolerate sitting continuously for 60 minutes.
- • 5. Local factors potentially worsened by intensive robot-aided arm therapy and computer-based training: active seizures within 3 months, spasticity of Modified Ashworth Scale grades \>2 skin wounds, shoulder, arm pain VAS \> 5/10, active upper limb fractures, arthritis, fixed upper limb flexion contractures.
- • 6. Hemianesthesia of affected limb.
- • 7. History of dementia, severe depression, agitation, or behavioural problems.
- • 8. Pregnancy or lactation in females
- • 9. Absence of reliable carer to provide supervision during home training
About Tan Tock Seng Hospital
Tan Tock Seng Hospital (TTSH) is a leading healthcare institution in Singapore, renowned for its commitment to excellence in patient care, education, and research. As a key player in the clinical research landscape, TTSH actively sponsors and conducts clinical trials across various medical specialties, aiming to advance medical knowledge and improve treatment outcomes. The hospital's robust infrastructure, multidisciplinary expertise, and strong collaborative ties with academic and research institutions enable it to facilitate innovative studies that adhere to the highest ethical and regulatory standards. Through its dedication to clinical research, TTSH strives to contribute significantly to the evolving field of medicine and enhance the health and well-being of the community it serves.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Singapore, , Singapore
Patients applied
Trial Officials
Karen Chua
Principal Investigator
Tan Tock Seng Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported